Literature DB >> 16519003

Update on nasal polyps: etiopathogenesis.

Virat Kirtsreesakul1.   

Abstract

PURPOSE OF REVIEW: Nasal polyps is a common ENT disease with high medical failure and recurrence rate, reflecting unknown pathogenesis. The present review is an update on the etiopathogenesis of nasal polyps. RECENT FINDING: Several mechanisms have been proposed for the formation of nasal polyps, including allergy, mucosal allergy, autonomic imbalance, nitric oxide, superantigens, infection, abnormal transepithelial ion transport, mucopolysaccharide abnormality, mechanical obstruction and epithelial rupture. Eosinophils comprises more than 60% of the cell population. Activated T cells, mast cells and plasma cells are also increased compared with the normal nasal mucosa. The stroma has numerous mediators, including cytokines, growth factors, adhesion molecules, and immunoglobulins. Both Th1 and Th2 types of cytokines are upregulated independent of the atopic status. An increased production of GM-CSF, IL5, RANTES and eotaxin can contribute to chronic eosinophilic inflammation by regulating the migration, survival and activation of eosinophils.
CONCLUSION: Nasal polyps is a multifactorial disease, with infectious, noninfectious, inflammation, anatomic and genetic abnormalities. Chronic inflammation remains the central major factor in nasal polyps.

Entities:  

Mesh:

Year:  2005        PMID: 16519003

Source DB:  PubMed          Journal:  J Med Assoc Thai        ISSN: 0125-2208


  5 in total

1.  Matrix metalloproteinase-9 gene polymorphisms in nasal polyposis.

Authors:  Ling-Feng Wang; Chen-Yu Chien; Chih-Feng Tai; Wen-Rei Kuo; Edward Hsi; Suh-Hang Hank Juo
Journal:  BMC Med Genet       Date:  2010-06-09       Impact factor: 2.103

2.  Are neutrophil, platelet and eosinophil-to-lymphocyte ratio and red blood cell distribution width can be used for nasal polyposis?

Authors:  Ahmet Kara; Mehmet Guven; Mahmut Sinan Yilmaz; Deniz Demir; Halil Elden
Journal:  Eur Arch Otorhinolaryngol       Date:  2017-11-30       Impact factor: 2.503

3.  Indications, efficacy, and safety of intranasal corticosteriods in rhinosinusitis.

Authors:  Paul C Potter; Ruby Pawankar
Journal:  World Allergy Organ J       Date:  2012-01-13       Impact factor: 4.084

4.  Effect Of Bevacizumab On Growth Of Human Nasal Polyposis In Vitro; An Off-Label Use Of Anti-Angiogenic Agent For Nasal Polyposis Treatment.

Authors:  Shadman Nemati; Faeze Keihanian; Amin Saeidinia; Mahdi Bakhshaei
Journal:  Drug Des Devel Ther       Date:  2019-09-24       Impact factor: 4.162

5.  Comparison of natural ostiodilatation and endoscopic sinus surgery in the same patient with chronic sinusitis.

Authors:  Ahmet Kutluhan; Hüseyin Çetin; Hayati Kale; Özmen Kara; Halil İbrahim Mişe; Tolga Oğuzhan; Kadir Şinasi Bulut
Journal:  Braz J Otorhinolaryngol       Date:  2018-10-22
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.